Fetal Growth Assessment and Intrauterine Growth Restriction

Fetal growth assessment is the antenatal evaluation of whether a fetus is growing as expected for its gestational age, and intrauterine growth restriction (also called fetal growth restriction) is the condition in which a fetus fails to reach its biologically determined growth potential. Distinguishing a constitutionally small but healthy fetus from one that is pathologically restricted is a central, and difficult, task of fetal medicine.

Definition

Intrauterine growth restriction is the failure of a fetus to achieve its expected growth potential, typically operationalized through ultrasound estimates of fetal weight below a population or customized percentile threshold combined with Doppler or growth-trajectory evidence of placental insufficiency, and distinguished from small-for-gestational-age, which denotes size below a threshold without implying pathology.

Scope

The entry covers how fetal size and growth are measured by ultrasound biometry, how growth restriction is defined and distinguished from small-for-gestational-age, the role of Doppler velocimetry in characterizing placental dysfunction, and the early- versus late-onset distinction. It is a reference topic, not clinical guidance on timing of delivery or management.

Core questions

• How is a pathologically growth-restricted fetus distinguished from a constitutionally small one?
• Which biometric and Doppler parameters best identify placental insufficiency?
• How do early-onset and late-onset growth restriction differ in mechanism and course?
• What reference standards (population versus customized) should define abnormal growth?

Key concepts

• Ultrasound fetal biometry and estimated fetal weight
• Small-for-gestational-age versus growth restriction
• Placental insufficiency
• Umbilical artery Doppler
• Middle cerebral artery Doppler and cerebroplacental ratio
• Ductus venosus Doppler
• Early-onset versus late-onset growth restriction
• Customized versus population growth charts

Mechanisms

Most clinically important fetal growth restriction reflects placental insufficiency: inadequate maternal-fetal perfusion limits oxygen and nutrient delivery, prompting fetal adaptation. Increasing umbilical artery resistance, redistribution of blood flow toward the brain (the 'brain-sparing' fall in middle cerebral artery resistance and the cerebroplacental ratio), and, in advanced cases, abnormal ductus venosus waveforms reflect a progression of fetal compromise. Early-onset restriction is more strongly tied to severe placental disease and is often monitored with venous Doppler, whereas late-onset restriction tends to show subtler placental dysfunction (Lees et al., 2013; McCowan et al., 2018).

Clinical relevance

Growth assessment is part of routine antenatal surveillance, and recognizing growth restriction is central to appraising obstetric ultrasound evidence because restricted fetuses carry elevated risks of adverse perinatal outcome. This entry describes how growth is evaluated and how restriction is defined; it is not a basis for individual decisions about monitoring or delivery.

Epidemiology

Definitions of restriction vary, but fetuses below conventional growth thresholds make up roughly the lowest several percent of the size distribution, and growth restriction is a leading antecedent of stillbirth and perinatal morbidity. Global birthweight and fetal-weight reference standards have been developed to standardize identification across populations (Mikolajczyk et al., 2011).

Evidence & guidelines

A Delphi consensus has defined fetal growth restriction by combining biometric thresholds with Doppler and growth-trajectory criteria to harmonize terminology (Gordijn et al., 2016), and ISUOG provides standards for performing and interpreting fetal biometry (Salomon et al., 2019). National guidelines differ in thresholds and surveillance approaches, a divergence reviewed by McCowan et al. (2018), while the TRUFFLE cohort informed understanding of monitoring in early-onset restriction (Lees et al., 2013).

History

Early antenatal growth assessment relied on symphysis-fundal height and indirect clinical estimates; the spread of real-time ultrasound biometry from the 1970s onward and of Doppler velocimetry in the 1980s-1990s transformed the field, and recent decades have seen efforts to standardize growth references and consensus definitions that separate constitutional smallness from true growth restriction.

Debates

Should growth charts be population-based or customized?

Customized charts adjust expected size for maternal characteristics in an effort to better separate constitutional smallness from pathological restriction, but whether they outperform standardized population or international references in predicting adverse outcomes remains contested.

How should growth restriction be defined?

Definitions vary across guidelines in the percentile thresholds and Doppler criteria they require; the Delphi consensus sought common ground, but operational disagreement persists between research and clinical settings.

Seminal works

• gordijn-2016
• lees-2013
• salomon-2019

Frequently asked questions

What is the difference between small-for-gestational-age and growth restriction?

Small-for-gestational-age describes a fetus measuring below a size threshold, which may simply be constitutionally small and healthy, whereas growth restriction implies that the fetus has failed to reach its growth potential because of an underlying problem such as placental insufficiency.

Why is Doppler ultrasound used in growth assessment?

Doppler velocimetry of the umbilical, middle cerebral, and ductus venosus vessels reflects placental resistance and fetal circulatory adaptation, helping distinguish a healthy small fetus from one showing physiological signs of compromise.